Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

50.8K
Overview
50.8K
Cancer Vaccines01:30

Cancer Vaccines

868
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
868
Conjugated Proteins02:50

Conjugated Proteins

25.7K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
25.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

827
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
827
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.1K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Cross-reactivity00:42

Cross-reactivity

32.7K
Overview
32.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatic Evolution of a Germline Antibody Expands its Breadth to Neutralize Early SARS-CoV-2 Omicron Variants.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Structural basis for distinct protective mechanisms of IGHV3-23 antibodies targeting influenza hemagglutinin stem.

Nature communications·2026
Same author

TRIM21 is a molecular rheostat for influenza A virus replication.

bioRxiv : the preprint server for biology·2026
Same author

Compartmentalized cytokine networks and systemic immune remodeling in bovine mammary H5N1 infection.

bioRxiv : the preprint server for biology·2026
Same author

B cell imprinting in children impairs antibodies to the haemagglutinin stalk.

Nature·2026
Same author

SARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities.

Genome biology·2026

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.3K

COVID-19 vaccines: Knowing the unknown.

Huibin Lv1, Nicholas C Wu2, Chris K P Mok1

  • 1HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

European Journal of Immunology
|May 22, 2020
PubMed
Summary

Developing vaccines for SARS-CoV-2 (the virus that causes COVID-19) is crucial. Past coronavirus vaccine research offers insights, but knowledge gaps in immunology and vaccinology still need addressing for successful COVID-19 vaccine development.

Keywords:
COVID-19SARS-CoV-2Vaccine

More Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.3K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.9K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • The global pandemic caused by SARS-CoV-2 (the virus responsible for COVID-19) has accelerated vaccine development efforts worldwide.
  • Previous research on vaccines for other coronaviruses, including Feline Infectious Peritonitis Virus (FIPV), Severe Acute Respiratory Syndrome (SARS), and Middle East Respiratory Syndrome (MERS), provides a foundation for SARS-CoV-2 vaccine strategies.

Purpose of the Study:

  • To identify critical knowledge gaps in SARS-CoV-2 vaccine development.
  • To leverage insights from historical coronavirus vaccine research to inform current efforts.
  • To discuss areas requiring further investigation in immunology and vaccinology relevant to COVID-19 vaccines.

Main Methods:

  • Review of existing literature on coronavirus vaccine development.
  • Analysis of knowledge gaps specific to SARS-CoV-2.
  • Comparative study of lessons learned from FIPV, SARS, and MERS vaccine research.

Main Results:

  • Significant progress has been made in COVID-19 vaccine development since the outbreak began.
  • Key knowledge gaps exist, both specific to SARS-CoV-2 and fundamental to broader immunological and vaccinology principles.
  • Past coronavirus vaccine research offers valuable, though not exhaustive, guidance.

Conclusions:

  • Despite challenges and existing knowledge gaps, the rapid progress in COVID-19 research fosters optimism for timely vaccine development.
  • Addressing identified gaps in immunology and vaccinology is essential for creating effective and safe SARS-CoV-2 vaccines.
  • Continued research and international collaboration are vital for overcoming hurdles in vaccine development.